Mitobridge, Inc.
Records under this name other than the patents Mitobridge, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,420,934 | Ppar Agonists Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,188,627 | Ppar Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,399,958 | Ppar Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,479,775 | Ppar Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,906,885 | Ppar Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,578,052 | Ppar Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,611,790 | Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,874,641 | Methods of Treating Acute Kidney Injury Formerly held In force · High confidence | In force | High confidence | |
| US 10,927,094 | Crystalline and salt forms of PPAR agonist compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,530,192 | Crystalline and salt forms of PPAR agonist compounds Formerly held In force · From the USPTO record | In force | From the USPTO record |